Securities Registration (section 12(b)) (8-a12b)
October 07 2014 - 6:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
NeuroSigma,
Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
26-3105690 |
(State of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
10960 Wilshire Boulevard, Suite 1910, Los Angeles, California |
|
90024 |
(Address of principal executive offices) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
to be so registered |
|
Name of each exchange on which
each class is to be registered |
Common Stock, $0.0001 par value |
|
The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box. x
If this form relates to the registration of a
class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨
Securities Act registration statement file number to which this form relates: 333-198374 (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
None
(title of class)
Item 1. |
Description of Registrants Securities to be Registered. |
A description of the
shares of common stock, par value $0.0001 per share, of NeuroSigma, Inc. (the Company) being registered hereunder is set forth under the caption entitled Description of Capital Stock in the Companys Registration
Statement on Form S-1 (File No. 333-198374), as initially filed with the Securities and Exchange Commission on August 26, 2014, as amended (the Registration Statement), and in the prospectus included in the Registration
Statement to be filed separately by the Company with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be deemed to be incorporated by reference herein.
Under the Instructions as to Exhibits section of Form 8-A, no
exhibits are required to be filed because no other securities of the Company are to be registered on The NASDAQ Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration
statement to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
NEUROSIGMA, INC. |
|
|
|
|
Date: October 6, 2014 |
|
|
|
By: |
|
/s/ Leon Ekchian |
|
|
|
|
Name: |
|
Leon Ekchian |
|
|
|
|
Title: |
|
President and Chief Executive Officer |
NEUROSIGMA, INC. (NASDAQ:NSIG)
Historical Stock Chart
From Jun 2024 to Jul 2024
NEUROSIGMA, INC. (NASDAQ:NSIG)
Historical Stock Chart
From Jul 2023 to Jul 2024